Here’s What Tocqueville Asset Management Has Been Buying and Selling: Sarepta Therapeutics Inc (SRPT), Amarin Corporation plc (AMRN)

Every quarter, many money managers have to disclose what they’ve bought and sold, via “13F” filings. Their latest moves can shine a bright light on smart stock picks.

Today, let’s look at Tocqueville Asset Management, which is a portfolio manager with a contrarian bent, believing that “the best investment results over time are achieved outside the mainstream consensus” and seeking “undervalued companies that possess long-term earnings power.”

Sarepta Therapeutics IncThe company’s reportable stock portfolio totaled $8.9 billion in value as of Dec. 31, 2012.

Interesting developments
So what does Tocqueville’s latest quarterly 13F filing tell us? Here are a few interesting details:

The biggest new holdings are FedEx Corporation (NYSE:FDX) and Canadian miner Ivanplats. Other new holdings of interest include Halcon Resources Corp (NYSE:HK) and Sarepta Therapeutics Inc (NASDAQ:SRPT) . Oil and gas company Halcon has been growing by acquiring assets such as shale-field properties and is expected to grow by 30% annually in the next few years. Sarepta, a biotech developing the promising Duchenne muscular dystrophy drug eteplirsen, nearly tripled in a single day recently and some expect further growth. There’s little certainty, though, until or unless the drug receives FDA approval.

Among holdings in which Tocqueville increased its stake was rare-earth elements producer Molycorp Inc (NYSE:MCP) , which has been struggling in a tough environment and recently worried investors with a bigger-than-many-expected share offering and debt issuance. (Some worry about further capital needs in the near future.) The stock is down a whopping 75% over the past year,

Tocqueville reduced its stake in lots of companies, including General Electric Company (NYSE:GE) . The company’s recent fourth-quarter report featured a growing backlog of orders (hitting $210 billion), and it has been expanding in areas such as mining and natural gas infrastructure. In a recent Motley Fool Money Roundtable, our analysts discussed another huge GE asset: its financial arm.

Finally, Tocqueville’s biggest closed positions included Barrick Gold Corporation (USA) (NYSE:ABX) and Kaiser Aluminum Corp. (NASDAQ:KALU). Other closed positions of interest include Amarin Corporation plc (ADR) (NASDAQ:AMRN) , a late-stage cardiovascular-focused biotech company with a promising drug to lower triglycerides. Some bulls see its newly approved drug, Vascepa, as underappreciated while others are waiting to see how successful its launch is. There’s speculation that the company will be acquired by a big pharmaceutical company, too.

We should never blindly copy any investor’s moves, no matter how talented the investor. But it can be useful to keep an eye on what smart folks are doing. 13-F forms can be great places to find intriguing candidates for our portfolios.

The article Here’s What This $9 Billion Contrarian Has Been Buying and Selling originally appeared on Fool.com and is written by Selena Maranjian.

Longtime Fool contributor Selena Maranjian, whom you can follow on Twitterhas no position in any stocks mentioned. The Motley Fool recommends FedEx. The Motley Fool owns shares of General Electric Company.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!